SEARCH

SEARCH BY CITATION

LITERATURE CITED

  • Bodo M, Lilli C, Aisa MC, Scapoli L, Bellucci C, Rinaldi E, Tosi L, Baroni T, Conte C, Bellocchio S, Carinci F, Stabellini G, Carinci P. 2002. Basic fibroblast growth factor: effects on matrix remodeling, receptor expression, and transduction pathway in human periosteal fibroblasts with FGFR2 gene mutation. J Interferon Cytokine Res 22:621630.
  • Bouten CV, Oomens CW, Baaijens FP, Bader DL. 2003. The etiology of pressure ulcers: skin deep or muscle bound? Arch Phys Med Rehabil 84:616619.
  • Ciulla TA, Rosenfeld PJ. 2009. Antivascular endothelial growth factor therapy for neovascular age-related macular degeneration. Curr Opin Ophthalmol 20:158165.
  • Damico FM. 2007. Angiogenesis and retinal diseases. Arq Bras Oftalmol 70:547553.
  • Dor Y, Klewer SE, McDonald JA, Keshet E, Camenisch TD. 2003. VEGF modulates early heart valve formation. Anat Rec A Discov Mol Cell Evol Biol 271:202208.
  • Douwes DP, Kuipers-Dijkshoorn NJ, Baelde HJ, van der Mey AG, Hogendoorn PC, Cornelisse CJ. 2007. Basic fibroblast growth factor and fibroblastic growth factor receptor-1 may contribute to head and neck paraganglioma development by an autocrine or paracrine mechanism. Hum Pathol 38:7985.
  • Ellman MB, An HS, Muddasani P, Im HJ. 2008. Biological impact of the fibroblast growth factor family on articular cartilage and intervertebral disc homeostasis. Gene 420:8289.
  • Fava RA, Olsen NJ, Spencer-Green G, Yeo KT, Yeo TK, Berse B, Jackman RW, Senger DR, Dvorak HF, Brown LF. 1994. Vascular permeability factor/endothelial growth factor (VPF/VEGF): accumulation and expression in human synovial fluids and rheumatoid synovial tissue. J Exp Med 180:341346.
  • Gefen A. 2008. Bioengineering models of deep tissue injury. Adv Skin Wound Care 21:3036.
  • Hoff JM, Bjerke LW, Gravem PE, Hagen EM, Rekand T. 2012. Pressure ulcers after spinal cord injury. Tidsskr Nor Laegeforen 132:838839.
  • Kaiser R, Dubovy P, Haninec P. 2011. Vascular endothelial growth factor. Cesk Fysiol 60:4851.
  • Kimura M, Shibahara N, Hikiami H, Yoshida T, Jo M, Kaneko M, Nogami T, Fujimoto M, Goto H, Shimada Y. 2011. Traditional Japanese formula kigikenchuto accelerates healing of pressure-loading skin ulcer in rats. Evid Based Complement Alternat Med 2011:592791.
  • Kuhn MC, Willenberg HS, Schott M, Papewalis C, Stumpf U, Flohe S, Scherbaum WA, Schinner S. 2012. Adipocyte-secreted factors increase osteoblast proliferation and the OPG/RANKL ratio to influence osteoclast formation. Mol Cell Endocrinol 349:180188.
  • Larrivee B, Karsan A. 2000. Signaling pathways induced by vascular endothelial growth factor (review). Int J Mol Med 5:447456.
  • Mammoto A, Connor KM, Mammoto T, Yung CW, Huh D, Aderman CM, Mostoslavsky G, Smith LE, Ingber DE. 2009. A mechanosensitive transcriptional mechanism that controls angiogenesis. Nature 457:11031108.
  • Mizia-Malarz A, Sobol G, Wos H. 2008. Proangiogenic factors: vascular-endothelial growth factor (VEGF) and basic fibroblast growth factor–the characteristics and function. Przegl Lek 65:353357.
  • Nguyen PK, Smith AL, Reynolds KJ. 2008. A literature review of different pressure ulcer models from 1942–2005 and the development of an ideal animal model. Australas Phys Eng Sci Med 31:223225.
  • Nugent MA, Iozzo RV. 2000. Fibroblast growth factor-2. Int J Biochem Cell Biol 32:115120.
  • Przybylski M. 2009. A review of the current research on the role of bFGF and VEGF in angiogenesis. J Wound Care 18:516519.
  • Pufe T, Paulsen F, Petersen W, Mentlein R, Tsokos M. 2003. The angiogenic peptide vascular endothelial growth factor (VEGF) is expressed in chronic sacral pressure ulcers. J Pathol 200:130136.
  • Robson MC, Hill DP, Smith PD, Wang X, Meyer-Siegler K, Ko F, VandeBerg JS, Payne WG, Ochs D, Robson LE. 2000. Sequential cytokine therapy for pressure ulcers: clinical and mechanistic response. Ann Surg 231:600611.
  • Ryuto M, Ono M, Izumi H, Yoshida S, Weich HA, Kohno K, Kuwano M. 1996. Induction of vascular endothelial growth factor by tumor necrosis factor alpha in human glioma cells. Possible roles of SP-1. J Biol Chem 271:2822028228.
  • Shibuya M. 2008. Vascular endothelial growth factor-dependent and -independent regulation of angiogenesis. BMB Rep 41:278286.
  • Stalmans I. 2005. Role of the vascular endothelial growth factor isoforms in retinal angiogenesis and DiGeorge syndrome. Verh K Acad Geneeskd Belg 67:229276.
  • Takayama M, Kuramoto Y, Okuyama R, Yamasaki K, Aiba S. 2010. The exudate of pressure ulcers contains a substantial amount of vascular endothelial growth factor. Tohoku J Exp Med 221:315319.
  • Wang XL. 2011. Research progress in animal models and molecular mechanism of pressure ulcers. J Nurs Sci 26:9092.
  • Wang XL, Huang F, Huang YR. 2012. Experiment study of recombinant human epidermal growth factor in rats Stage III pressure ulcer model. Chinese Nurs Res 26:395396.